We recently partnered with the Venture Capital Unit at the Department for Business and Trade to host the Physics Deep Tech Showcase, highlighting the UK’s most promising early-stage businesses to government stakeholders and deep tech investors. In the Med Tech category, we heard from innovative companies revolutionising healthcare: ➡️ Adam Bryant from CanSense - developing a non-invasive blood test using laser spectroscopy and AI for early bowel cancer detection, capable of identifying cancer and pre-cancerous polyps from a single sample. ➡️ Stuart Plant from Ceryx Medical Ltd - creating unique bioelectronic technology that restores natural heart-lung communication, offering a transformative approach to treating heart failure. ➡️ Jeremy Holland from Crainio - enabling simple, affordable, risk-free, and non-invasive measurement of intracranial pressure (ICP) to improve patient safety and outcomes. ➡️ Hemmel Amrania PhD Breast Cancer Diagnostics from Digistain® - eliminating guesswork in breast cancer treatment by measuring chemical changes associated with the disease, empowering physicians to quickly and accurately determine chemotherapy needs. ➡️ Euan Allen from Siloton - introducing a revolutionary personal eye scanner for patients with age-related macular degeneration (AMD), improving patient wellbeing, reducing healthcare system pressures, and providing unprecedented insights into disease progression through granular longitudinal data. ➡️ Dan Cathie from Silveray - pioneering flexible colour X-ray cameras based on proprietary semiconductors, opening new analytical capabilities in industry and transforming medical diagnostics. These groundbreaking companies exemplify how UK medtech innovation is transforming early detection, treatment, and patient care. #IOPVentureCapital #IOPPhysicsDeepTech #MedTech #PhysicsTech #MedTechInnovation
-
-
-
-
-
+1